Replies to post #26244 on Marker Therapeutics Inc (MRKR)

[microcapbiotech]

Sounds good to me - “With promising early clinical results in multiple cancer indications, we believe our therapies may represent the next major leap forward in cell therapy for cancer,” said Peter L. Hoang, President and CEO of Marker Therapeutics.
This just started in March 2019 when OutcomeRx and Vineti announced a new alliance to build patient-centered digital and services solutions to streamline cell and gene therapies.
One month later, Marker taking advantage of it, GREAT. If it helps us do trials faster, better, more efficiently, and produces better results, sounds good to me.